SAVA FY 2018 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$69,000

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-0.61

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$20M

Total Liabilities

$511,000

Stockholders' Equity

$20M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$69,000	-$68,000	-1.5%
Operating Income	-$7M	-$12M	+44.2%
Net Income	-$7M	-$12M	+45.0%